Qualderm Introduces Revolutionary Radiation Treatment for Skin Cancer Patients

Qualderm's Innovative Approach to Skin Cancer Treatment

Qualderm has made a significant leap in skincare by introducing a non-surgical treatment for certain types of skin cancer, thanks to their investment in advanced radiation technology. This new approach is particularly aimed at patients who are eligible for treatment, offering them an alternative to traditional surgical methods.

Superficial Radiation Therapy (SRT) is now available at 13 affiliated practice locations across various states, including Illinois, Indiana, Michigan, Tennessee, Texas, and Virginia. The therapy specifically targets non-melanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma, through the use of low-energy X-rays. This innovative technique allows for the precise targeting of cancer cells both on and just below the skin surface while minimizing exposure to surrounding healthy tissues, effectively preserving the integrity of the skin.

One of the most appealing aspects of SRT is that it does not require incisions, stitches, or any form of anesthesia. Instead, the treatment is administered over a series of office visits, making it a less invasive option for patients compared to conventional surgery. Dr. Jake E. Turrentine, the Chief Medical Officer at Qualderm and a board-certified dermatologist, emphasizes that patients deserve a comprehensive approach to their skin cancer care, tailored to their individual diagnosis, health condition, and personal treatment goals.

By developing SRT capabilities in-house, Qualderm streamlines the patient experience, eliminating the uncertainty and complications associated with transferring care to other facilities. This innovation not only simplifies scheduling but also brings essential care closer to patients’ residences, enabling them to receive expert, personalized treatment within their community.

SRT is particularly beneficial for those patients who might be at greater risk during surgery or for those whose cancers are located in specific areas where surgical intervention could necessitate complicated reconstruction. Each patient's diagnosis, including tumor characteristics and overall health, is evaluated by physicians, who then discuss the appropriate treatment options, including the associated benefits and risks.

For patients interested in exploring the SRT option, they are encouraged to contact one of the participating practices to schedule a consultation. This initial meeting will help determine whether SRT is an appropriate treatment for their specific condition.

Qualderm’s dedication to expanding treatment options and enhancing patient care reflects its commitment to providing comprehensive skin cancer management and addressing various skin health needs. The organization currently supports a network of over 150 dermatology practices that offer a wide range of medical, surgical, and cosmetic dermatology services. Through strong physician leadership and an unwavering commitment to clinical excellence, Qualderm ensures its affiliates can deliver tailored care to their patients, at every step of their healthcare journey.

To learn more about Qualderm and its innovative services, you can visit their website at Qualderm.com.

With these advancements, Qualderm is not just changing the way skin cancer is treated but is also paving the way for a future where effective, patient-centered care is the norm, making a significant impact on the lives of those affected by skin cancer.